Chagas disease. The use of serology to establish drug efficacy. Value and limitations*
DOI:
https://doi.org/10.5216/rpt.v50i4.71556Resumo
*Presented at the ”Consultative Meeting on the Strategic and Operational Aspects for the Clinical Development of Trypanocidal Drugs for Chagas Disease, 23-24 April 2007, Buenos Aires, Argentina.”, sponsored by TDR, WHO.
This publication is dedicated to one of the authors (deceased) due to his life dedicated to Chagas disease and particularly to this subject. After 14 years, this material is still valid.
Downloads
Os dados de download ainda não estão disponíveis.
Downloads
Publicado
2022-01-17
Edição
Seção
RELATORIO / SHORT REPORT
Licença
The manuscript submission must be accompanied by a letter signed by all authors stating their full name and email address, confirming that the manuscript or part of it has not been published or is under consideration for publication elsewhere, and agreeing to transfer copyright in all media and formats for Journal of Tropical Pathology.
Como Citar
O. LUQUETTI, A.; RASSI**, A. Chagas disease. The use of serology to establish drug efficacy. Value and limitations*. Revista de Patologia Tropical / Journal of Tropical Pathology, v. 50, n. 4, p. 333–336, 17 jan.2022.
